Using data from the compulsory Medical Birth Registry of Norway, the authors investigated the effect of maternal multiple sclerosis (MS) on pregnancy, delivery, and birth outcome in 649 births by MS mothers and 2.1 million control births. The mothers with MS had a higher proportion of neonates small for gestational age and also more frequent induction and operative interventions during delivery.
Results. Maternal and pregnancy characteristics are shown in table 1. In the MS group, both urinary tract infections (p ϭ 0.001) and inflammatory arthritis (rheumatoid arthritis or ankylosing spondylitis) (p ϭ 0.018) were increased compared with the control group. The overall rate of obstetric complications did not differ between the groups. Operative deliveries (use of forceps, vacuum extractor, or cesarean delivery) were more frequent in the MS group compared with the control group (odds ratio [OR] 1.54; 95% CI 1.29 to 1.84; p Ͻ 0.001, adjusted for time period). Table 2 illustrates that the MS group had increased use of forceps in time period II, but this did not lead to increased rate of postpartum hemorrhage in the total MS group. A higher cesarean delivery rate in the MS group was seen in all time periods (see table 2), although it was not significantly higher in time period I because of low numbers. The higher cesarean delivery rate in the MS group was due to an increase in planned and not emergency deliveries. In a separate analysis of vaginal births, MS births had higher rates of induction of labor (OR 1.30; 95% CI 1.03 to 1.64; p ϭ 0.027), increased frequency of slow progression of the second stage of labor (7.1% vs 3.7%; OR 1.61; 95% CI 1.15 to 2.23; p ϭ 0.005, adjusted for time period), and increased use of forceps (4.9% vs 2.9%; OR 1.71; 95% CI 1.16 to 2.54; p ϭ 0.007).
The proportion of neonates who were small for gestational age was increased in the MS group (OR 1.45; 95% CI 1.14 to 1.84; p ϭ 0.003, adjusted for mother's age and time period; table 3). This association was even stronger when we compared term births (37 weeks or more) only (OR as compared with controls 1.61; 95% CI 1.26 to 2.05; p Ͻ 0.001, adjusted for mother's age and time period). The Apgar scores, perinatal mortality, and birth defects did not differ between the MS and control groups.
Discussion. This nationwide historic cohort study showed that MS mothers had an increased rate of neonates being small for gestational age. Reduced mean birth weight and length but a normal head circumference indicates that these neonates had had insufficient nutrition during pregnancy. Fetal growth retardation is found in other immune medi-ated diseases, 3, 4 but no shared pathogenic mechanism with MS is known. Possible explanations include maternal factors such as comorbidity and deficient nutritional status. However, the MS group did not have an increased rate of conditions known to decrease birth weight, and previous data on dietary habits and body composition 5 do not support insufficient nutrition in MS populations. Factors related to MS itself may therefore be of importance. Villard-Mackintosh and Vessey 6 suggested an excess of low-birth-weight neonates among mothers giving birth before they were diagnosed with MS. Moreover, bowel, bladder, and sexual dysfunction are frequent manifestations of MS. 7 Therefore, alterations in the tubes and uterine function due to neuronal dysfunction in pelvic organs could produce suboptimal intrauterine conditions and influence fetal growth. This is supported by the increase in urinary tract infections and the increased need for induction of labor in this group.
Despite the increased level of planned cesarean delivery in the MS group, the birth process was often affected in those with vaginal deliveries. Increased need for induced labor, slow progression of labor, and increased use of forceps assistance demonstrates an increased need of intervention during birth. We suggest that MS-related symptoms such as neuromuscular perineal weakness and spasticity in addition to fatigue and exhaustion are important factors and must be evaluated before delivery in each case. We assume that both the number of complications and the need for intervention during delivery would have been higher if the rate of cesarean delivery had been held at the level of the control population.
The Medical Birth Registry of Norway has been established as a database for epidemiologic research, but it does not give detailed information on the MS diagnosis, and the proportion of MS women who give birth is not known. As a result, the sensitivity of the MS diagnosis in our study is not known. However, MS diagnosis is considered reliable because of the widespread attitude that MS is a common (incidence 5 to 6 per 100,000 persons per year 8 ), serious, and specific disease that interferes with family planning. The validity of rheumatic disease in the Medical Birth Registry of Norway has been confirmed and found to be high, 9 this also being true for myasthenia gravis. 10 Along with this, we consider the specificity of the MS diagnosis in the Medical Birth Registry to be high.
This study demonstrates an important impact of MS on pregnancy, delivery, and the newborn, and the results indicate a need for close follow-up of this patient group regarding obstetric care. 
